FDA Adverse Event Injury Summary report: N

GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS

MDR report key: 13114635 · Received December 29, 2021

Report

Report Number
3007284313-2021-01732
Event Type
Injury
Date Received
December 29, 2021
Date of Event
December 22, 2021
Report Date
March 16, 2022
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
MIH
UDI-DI
00733132651030
PMA / PMN Number
P200030
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

G3/G4, PMA/510K NUMBER INCORRECTLY ENTERED PREVIOUSLY AND CHANGED TO P200030.

Additional Manufacturer Narrative · 0

H6 CODE 213 - NO DEVICE PROBLEM FOUND: A REVIEW OF MANUFACTURING RECORDS VERIFIED THAT THE LOT INVOLVED IN THIS COMPLAINT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 0

ON (B)(6) 2021 THE PATIENT UNDERWENT TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH GORE ® EXCLUDER ® CONFORMABLE AAA ENDOPROSTHESIS (CXT261412) AND WITH GORE ® EXCLUDER ® AAA ENDOPROSTHESES (PLC14100, PLC201200, AND PLC121400). THE PLC 121400 WAS EXTENDED INTO THE IPSILATERAL LIMB ON THE RIGHT SIDE OF THE PATIENT. A 3CM OF OVERLAP WAS OBSERVED BETWEEN THE CXT261412 AND THE PLC121400 AT THE TIME OF THE PROCEDURE. A FOLLOW UP CT SCAN WAS PERFORMED ON AN UNSPECIFIED DATE AND IT WAS OBSERVED THAT THE THERE WAS NO OVERLAP BETWEEN CXT261412 AND THE PLC121400 ENDOPROSTHESES. THE PLC121400 HAD MIGRATED TO THE END OF THE IPSILATERAL LIMB ON THE CXT261412. A TYPE III ENDOLEAK WAS OBSERVED. ON (B)(6) 2021 A REINTERVENTION WAS PERFORMED IN WHICH A PLC 161400 WAS IMPLANTED TO TREAT THE TYPE III ENDOLEAK. THE PATIENT TOLERATED THE PROCEDURE AND THE ENDOLEAK WAS RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2009960 GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES, INC. CXT261412 00733132651030

Patients

Seq Age Sex Outcome Treatment
1 71 YR Male Required Intervention| H| O